94 related articles for article (PubMed ID: 21612970)
1. Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France.
Fayard C; Bonaventure A; Benatru I; Roze E; Dumurgier J; Moisan F; Soumaré A; Houssinot J; Dupupet JL; Mazurie JL; Balaboi I; Houeto JL; Krim E; Ranoux D; Goldberg M; Imbernon E; Moreau T; Giroud M; Tzourio C; Elbaz A
Parkinsonism Relat Disord; 2011 Aug; 17(7):543-6. PubMed ID: 21612970
[TBL] [Abstract][Full Text] [Related]
2. Session 3 "Analyzer Workshop" evolution of therapeutic strategies in Parkinson's disease.
Yanagisawa N; Yamamoto M; Kikuchi S; Murata M; Ohkuma Y
J Neurol; 2004 Oct; 251 Suppl 7():vII24-30. PubMed ID: 15505751
[No Abstract] [Full Text] [Related]
3. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
Benbir G; Ozekmekçi S; Apaydin H; Delil S; Erginöz E
Clin Neurol Neurosurg; 2006 Dec; 108(8):726-32. PubMed ID: 16564615
[TBL] [Abstract][Full Text] [Related]
4. Initial pharmacotherapy in a population of veterans with Parkinson disease.
Swarztrauber K; Koudelka C; Brodsky MA
Neurology; 2006 May; 66(9):1425-6. PubMed ID: 16682678
[TBL] [Abstract][Full Text] [Related]
5. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
6. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Kondo T
J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
[TBL] [Abstract][Full Text] [Related]
7. Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China.
Li J; Chen D; Song W; Chen K; Cao B; Huang R; Yang R; Shang H
Clin Neurol Neurosurg; 2014 Mar; 118():16-20. PubMed ID: 24529223
[TBL] [Abstract][Full Text] [Related]
8. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
[TBL] [Abstract][Full Text] [Related]
9. [Update on current care guidelines. Parkinson's disease].
Reijo M; Atula S; Heikkinen E; Jaakkola MR; Pekka J; Keränen T; Martikainen K; Pekkonen E; Sotaniemi K;
Duodecim; 2010; 126(19):2289-90. PubMed ID: 21086687
[TBL] [Abstract][Full Text] [Related]
10. How should we treat a patient with early Parkinson's disease?
Tsouli S; Konitsiotis S
Int J Clin Pract; 2010 Aug; 64(9):1210-9. PubMed ID: 20653797
[TBL] [Abstract][Full Text] [Related]
11. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease therapy: treatment of early and late disease.
Jankovic J
Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic agonists in the treatment of Parkinson's disease: a review.
Piccoli F; Riuggeri RM
J Neural Transm Suppl; 1995; 45():187-95. PubMed ID: 8748625
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life.
Danisi F
Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548
[TBL] [Abstract][Full Text] [Related]
15. Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.
Laurencin C; Danaila T; Broussolle E; Thobois S
Rev Neurol (Paris); 2016; 172(8-9):512-523. PubMed ID: 27476416
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice. Diagnosis and initial management of Parkinson's disease.
Nutt JG; Wooten GF
N Engl J Med; 2005 Sep; 353(10):1021-7. PubMed ID: 16148287
[No Abstract] [Full Text] [Related]
17. Dopamine agonists in Parkinson's disease.
Yamamoto M; Schapira AH
Expert Rev Neurother; 2008 Apr; 8(4):671-7. PubMed ID: 18416667
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy in Parkinson's disease].
van Hilten JJ; Roos RA
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
[TBL] [Abstract][Full Text] [Related]
19. [Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review].
Bode M
Ugeskr Laeger; 2009 Oct; 171(41):2996-9. PubMed ID: 19814927
[TBL] [Abstract][Full Text] [Related]
20. Levodopa induced motor complications in Thai Parkinson's disease patients.
Kulkantrakorn K; Tiamkao S; Pongchaiyakul C; Pulkes T
J Med Assoc Thai; 2006 May; 89(5):632-7. PubMed ID: 16756048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
